
CHMP Backs Novo Nordisk’s Semaglutide for MASH, Opening Door to EU Approval
Austin Newman - February 15, 2026LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
February 15th is Angelman Syndrome Awareness Day 💙 Angelman Syndrome Foundation
Today we shine a light on Angelman syndrome — a rare neurogenetic condition that affects speech, movement, sleep, and development, but never a person’s capacity for joy, connection, and love. Behind every diagnosis is a child, teen, or adult with a unique personality, incredible strength, and a family advocating fiercely for their future.
Awareness brings understanding. Understanding brings support. And support brings progress toward better therapies, resources, and hope.
Join us in spreading awareness, amplifying voices, and celebrating the amazing individuals living with Angelman syndrome today and every day.
#AngelmanSyndrome #AngelmanAwareness #RareDisease #RareDiseaseCommunity #RareButNotAlone
... See MoreSee Less


- likes 0
- Shares: 2
- Comments: 0
From advanced imaging to targeted treatments, managing retinal vein occlusion is all about protecting your sight and preventing complications. Every patient's journey is different - and every story matters. If you're living with RVO, consider sharing your experience with us by clicking the link below: bit.ly/3VuxFDV #RetinaHealth #SeeClearly #PatientWorthy 🧐 ... See MoreSee Less


Childhood cancer doesn't discriminate. It affects children globally, but improved treatments and research give us hope. This International Childhood Cancer Awareness Day, help raise awareness and support the cause! #childhoodcancer #childhoodcancerawareness #PatientWorthy
Share your story with us here: bit.ly/4dV7gru
... See MoreSee Less



